NeoGenomics Dirección
Dirección controles de criterios 3/4
El CEO de NeoGenomics es Chris Smith , nombrado en Aug 2022, tiene una permanencia de 2.25 años. compensación anual total es $11.67M, compuesta por 8.6% salario y 91.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.5% de las acciones de la empresa, por valor de $9.93M. La antigüedad media del equipo directivo y de la junta directiva es de 2 años y 3.8 años, respectivamente.
Información clave
Chris Smith
Chief Executive Officer (CEO)
US$11.7m
Compensación total
| Porcentaje del salario del CEO | 8.6% |
| Permanencia del CEO | 2.3yrs |
| Participación del CEO | 0.5% |
| Permanencia media de la dirección | 2yrs |
| Promedio de permanencia en la Junta Directiva | 3.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Is NeoGenomics (NASDAQ:NEO) A Risky Investment?
Oct 16
Investors Appear Satisfied With NeoGenomics, Inc.'s (NASDAQ:NEO) Prospects As Shares Rocket 29%
Aug 01Is NeoGenomics (NASDAQ:NEO) A Risky Investment?
Jul 15Investors Interested In NeoGenomics, Inc.'s (NASDAQ:NEO) Revenues
Mar 30Investor Optimism Abounds NeoGenomics, Inc. (NASDAQ:NEO) But Growth Is Lacking
Dec 26Is NeoGenomics (NASDAQ:NEO) A Risky Investment?
Aug 23Risks To Shareholder Returns Are Elevated At These Prices For NeoGenomics, Inc. (NASDAQ:NEO)
Jul 16NeoGenomics (NASDAQ:NEO) Is Making Moderate Use Of Debt
Apr 18We Think NeoGenomics (NASDAQ:NEO) Has A Fair Chunk Of Debt
Jan 10NeoGenomics: Market Punishment Continues, But Looks Justified
Sep 30NeoGenomics grants CEO restricted shares, stock options
Aug 17Here's Why NeoGenomics (NASDAQ:NEO) Can Afford Some Debt
Aug 10NeoGenomics rises ~14% on strong Q2 result
Aug 09NeoGenomics gets new CEO
Jul 21NeoGenomics: Refrain From Portfolio Allocation, Negligible Upside Potential
Jun 28Is NeoGenomics (NASDAQ:NEO) Using Too Much Debt?
Apr 22Neogenomics: Poor Performance, CEO Departure Create Downward Share Price Spiral
Apr 08Why NeoGenomics, Inc. (NASDAQ:NEO) Could Be Worth Watching
Feb 11Is NeoGenomics (NASDAQ:NEO) Weighed On By Its Debt Load?
Jan 07NeoGenomics: Gambling On Growth
Dec 16Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$78m |
| Jun 30 2024 | n/a | n/a | -US$79m |
| Mar 31 2024 | n/a | n/a | -US$84m |
| Dec 31 2023 | US$12m | US$1m | -US$88m |
| Sep 30 2023 | n/a | n/a | -US$96m |
| Jun 30 2023 | n/a | n/a | -US$115m |
| Mar 31 2023 | n/a | n/a | -US$126m |
| Dec 31 2022 | US$15m | US$346k | -US$144m |
Compensación vs. Mercado: La compensación total de Chris($USD11.67M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD5.35M).
Compensación vs. Ingresos: La compensación de Chris ha sido consistente con los resultados de la empresa en el último año.
CEO
Chris Smith (61 yo)
2.3yrs
Permanencia
US$11,665,946
Compensación
Mr. Christopher Michael Smith, also known as Chris, serves as Chief Executive Officer at NeoGenomics Laboratories, Inc. since August 2022. He serves as Director at NeoGenomics Laboratories, Inc. since 2023...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 2.3yrs | US$11.67m | 0.50% $ 9.9m | |
| Chief Financial Officer | 1.9yrs | US$3.55m | 0.12% $ 2.3m | |
| President of Advanced Diagnostics | 2.8yrs | US$2.37m | 0.10% $ 2.0m | |
| President & COO of Informatics | 1.9yrs | US$4.69m | 0.084% $ 1.7m | |
| Chief Commercial Officer | 2yrs | US$3.01m | 0.078% $ 1.5m | |
| Chief Accounting Officer | 1.5yrs | sin datos | 0.011% $ 222.0k | |
| Vice President of Investor Relations & Communications | no data | sin datos | sin datos | |
| Executive VP of Business Development | 2.6yrs | sin datos | 0.033% $ 647.3k | |
| Chief Compliance Officer | 2.6yrs | sin datos | sin datos | |
| Chief Medical Officer | 3.8yrs | sin datos | sin datos | |
| Chief Culture Officer | 1.8yrs | sin datos | sin datos | |
| Head of Strategy & Transformation | less than a year | sin datos | sin datos |
2.0yrs
Permanencia media
51yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de NEO se considera experimentado (2 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 2.3yrs | US$11.67m | 0.50% $ 9.9m | |
| Independent Director | 4.3yrs | US$317.50k | 0.025% $ 487.8k | |
| Independent Chair of the Board | 9.4yrs | US$365.00k | 0.048% $ 943.0k | |
| Member of Scientific Advisory Board | 3.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 3.8yrs | sin datos | sin datos | |
| Independent Director | 1.4yrs | US$276.23k | 0.0088% $ 174.1k | |
| Member of Scientific Advisory Board | 3.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 3.8yrs | sin datos | sin datos | |
| Independent Director | 7.3yrs | US$309.20k | 0.028% $ 554.4k | |
| Member of Scientific Advisory Board | 3.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board & Independent Director | 9.4yrs | US$305.00k | 0.093% $ 1.8m | |
| Member of Scientific Advisory Board | 3.8yrs | sin datos | sin datos |
3.8yrs
Permanencia media
63yo
Promedio de edad
Junta con experiencia: La junta directiva de NEO se considera experimentada (3.8 años de antigüedad promedio).